R. Ferrer-Oliveras

发表

Evaluating the Effect of Pravastatin in Early-Onset Fetal Growth Restriction: A Nonrandomized and Historically Controlled Pilot Study

E. Carreras, J. Alijotas-Reig, M. Mendoza, 2020, American Journal of Perinatology.

Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes

G. Espinosa, A. Tincani, J. Alijotas-Reig, 2021, European journal of anaesthesiology.

Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review.

J. Alijotas-Reig, E. Llurba, R. Ferrer-Oliveras, 2018, Obstetrical & gynecological survey.

Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review

J. Alijotas-Reig, E. Llurba, R. Ferrer-Oliveras, 2017, Clinical Reviews in Allergy & Immunology.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

E. Andrès, G. Mahé, L. Chiche, 2018, Autoimmunity reviews.

Angiogenic factors for planning fetal surveillance in fetal growth restriction and small‐for‐gestational‐age fetuses: A prospective observational study

E. Carreras, M. Mendoza, R. Ferrer-Oliveras, 2022, BJOG : an international journal of obstetrics and gynaecology.

Obstetric antiphospholipid syndrome.

J. Alijotas-Reig, R. Ferrer-Oliveras, E. Esteve-Valverde, 2016 .

Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss.

M. Vilardell‐Tarrés, J. Alijotas-Reig, R. Ferrer-Oliveras, 2010, Fertility and sterility.

ORIGINAL ARTICLE: Are Anti‐Beta2‐Glycoprotein‐I Antibodies Markers for Recurrent Pregnancy Loss in Lupus Anticoagulant/Anticardiolipin Seronegative Women?

M. Vilardell‐Tarrés, J. Alijotas-Reig, E. Hermosilla, 2008, American journal of reproductive immunology.

Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets

J. Alijotas-Reig, E. Llurba, L. Cabero-Roura, 2012, Lupus.

Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies

G. Espinosa, A. Tincani, J. Alijotas-Reig, 2018, Medicina Clínica (English Edition).

Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.

G. Espinosa, A. Tincani, J. Alijotas-Reig, 2017, Medicina clinica.

Inherited thrombophilia in women with poor aPL‐related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort

G. Espinosa, A. Tincani, J. Alijotas-Reig, 2016, American journal of reproductive immunology.

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases.

G. Espinosa, R. Cervera, A. Tincani, 2015, Autoimmunity reviews.

Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease

J. Alijotas-Reig, R. Ferrer-Oliveras, E. Esteve-Valverde, 2016 .

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A preliminary first year report

J. Alijotas-Reig, R. Ferrer-Oliveras, Raquel Ferrer-Oliveras, 2012, Lupus.

sFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study

M. Pancorbo, E. Carreras, M. Mendoza, 2022, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.

G. Espinosa, R. Cervera, A. Tincani, 2020, Rheumatology.

AB0165 THE EUROPEAN REGISTRY ON OBSTETRIC ANTIPHOSPHOLIPID SYNDROME (EUROAPS): A SURVEY OF 1100 CONSECUTIVE CASES

R. Cervera, A. Tincani, J. Alijotas-Reig, 2019, Abstracts Accepted for Publication.

OP0282 OBSTETRIC ANTIPHOSPHOLIPID SYNDROME (OAPS) VS. WITH OBSTETRIC MORBIDITY RELATED WITH ANTIPHOSPHOLIPID ANTIBODIES (OMAPS): A SURVEY OF 1650 CASES FROM EUROAPS REGISTRY

G. Espinosa, J. Alijotas-Reig, A. Mékinian, 2019, Oral Presentations.

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.

G. Espinosa, R. Cervera, A. Tincani, 2019, Autoimmunity reviews.

Immunological and physiopathological approach of COVID-19 in pregnancy

J. Alijotas-Reig, M. Mendoza, L. Cabero-Roura, 2021, Archives of Gynecology and Obstetrics.

Anti-annexin A5 antibodies in women with spontaneous pregnancy loss.

M. Vilardell‐Tarrés, J. Alijotas-Reig, R. Ferrer-Oliveras, 2010, Medicina clinica.

EULAR recommendations for the management of antiphospholipid syndrome in adults

M. Ward, Y. Shoenfeld, K. Hambly, 2019, Annals of the rheumatic diseases.

Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.

F. Carrat, N. Costedoat-Chalumeau, N. Morel, 2017, Autoimmunity reviews.

Recurrent Kikuchi–Fujimoto disease during pregnancy: Report of case evolving into systemic lupus erythematosus and review of published work

M. Vilardell‐Tarrés, J. Alijotas-Reig, L. Cabero-Roura, 2008, The journal of obstetrics and gynaecology research.

Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group.

G. Espinosa, A. Tincani, J. Alijotas-Reig, 2023, Placenta.

[Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease].

J. Alijotas-Reig, R. Ferrer-Oliveras, E. Esteve-Valverde, 2016, Medicina clínica (Ed. impresa).